Apart from eliminating a significant portion of the tumour cells, cancer therapies such as chemotherapy also produce senescent tumour cells, which are also referred to as "zombi cells." Senescent cells do not proliferate, but regrettably, they create an atmosphere that is conducive to the gr
Tumour cells are known to be fickle sleepers, typically lying dormant in distant tissues for years before reactivating and producing metastasis. Numerous elements, ranging from cells and molecules to other components in the so-called tissue microenvironment, have been researched to determine
Scientists have developed an AI tool that can rapidly decode a brain tumour's DNA to determine its molecular identity during surgery, critical information that can take a few days to a few weeks under the current approach.
When the immune system's T cells are constantly stressed as a result of cancer or other chronic diseases, they suffer a process known as T cell fatigue. Our bodies cannot fight cancer without functioning T cells that attack tumour cells.
he immune system's T cells undergo a process known as T cell exhaustion when they are constantly stressed out as a result of cancer or other chronic disorders. Without functioning T cells, which destroy tumour cells, our bodies are unable to combat cancer. In order to increase the immune sys
Isolated from other cells in a laboratory dish, tumour cells won't reveal their actual nature. Rice University researchers created an improved tumour model that houses osteosarcoma cells alongside immune cells known as macrophages inside a three-dimensional framework designed to simulate bon
A new weapon in the arsenal of cancer cells' treatment resistance, according to a study conducted by the Garvan Institute of Medical Research, is the ability for them to respond randomly to chemotherapy.
According to recent research led by the Garvan Institute of Medical Research, cancer cells have an inbuilt randomness in their capacity to respond to chemotherapy, which is another weapon in their treatment resistance toolbox.
A small but significant metabolic difference between human and mouse lung tumour cells, has been discovered by Weill Cornell Medicine researchers, explaining a discrepancy in previous study results, and pointing toward new strategies for developing cancer treatments.
CAR T-cell therapy, a sort of cancer treatment in which the immune system's T cells are trained to attack tumour cells, was found to be effective in mice with ovarian cancer, according to a study.
According to a study, CAR T-cell therapy, a type of cancer treatment in which the immune system's T cells are trained to attack tumour cells, is successful in mice with ovarian cancer.